CFO
REGN icon

Collective Family Office’s Regeneron Pharmaceuticals REGN Stock Holding History

Collective Family Office’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-256
Closed -$225K – 182
2023
Q4 		$225K Sell
256
-99
-28% -$81.5K 0.08% 157
2023
Q3 		$292K Buy
355
+50
+16% +$39.3K 0.11% 135
2023
Q2 		$219K Buy
+305
New +$235K 0.09% 164
2022
Q3 		– Sell
-476
Closed -$281K – 194
2022
Q2 		$281K Buy
476
+172
+57% +$112K 0.12% 154
2022
Q1 		$212K Sell
304
-155
-34% -$98.1K 0.08% 182
2021
Q4 		$290K Sell
459
-19
-4% -$11.7K 0.11% 153
2021
Q3 		$289K Sell
478
-3
-0.6% -$1.86K 0.12% 141
2021
Q2 		$269K Sell
481
-75
-13% -$38K 0.12% 147
2021
Q1 		$263K Buy
+556
New +$271K 0.13% 144

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return